• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞高浸润预测淋巴结阴性乳腺癌不良临床结局。

High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer.

机构信息

The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China.

出版信息

PLoS One. 2013 Sep 30;8(9):e76147. doi: 10.1371/journal.pone.0076147. eCollection 2013.

DOI:10.1371/journal.pone.0076147
PMID:24098773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3786995/
Abstract

The tumor microenvironment is composed of tumor cells, fibroblasts, endothelial cells and infiltrating immune cells, which may inhibit or promote tumor growth and progression. The objectives of this retrospective study were to characterize the density of tumor-associated macrophages (TAMs) in breast cancer, and to correlate the density of TAMs with clinicopathological parameters. Paraffin-embedded specimens and clinicopathological data, including up to 5 years follow-up information, were obtained from 172 breast cancer patients. Immunohistochemical staining for CD68 (marker for macrophages) was performed and evaluated in a blinded fashion. We found that TAMs were significantly frequent in high histopathological grade breast cancer patients. Breast cancer patients with a high density of TAMs had significantly lower rates of disease-free survival and 5-year overall survival than patients with low density of TAMs. Furthermore, high-infiltration of TAMs indicated worse survival rate for patients with node-negative breast cancer. In conclusion, the number of TAMs in the tumor stroma is an independent predictor of survival time for breast cancer patients. High-infiltration of TAMs is a significant unfavorable prognostic factor for patients with invasive breast cancer and, as such, is a potentially useful prognostic marker for breast cancer.

摘要

肿瘤微环境由肿瘤细胞、成纤维细胞、内皮细胞和浸润的免疫细胞组成,这些细胞可能抑制或促进肿瘤的生长和进展。本回顾性研究的目的是描述乳腺癌中肿瘤相关巨噬细胞(TAMs)的密度,并将 TAMs 的密度与临床病理参数相关联。从 172 名乳腺癌患者中获得了石蜡包埋标本和临床病理数据,包括长达 5 年的随访信息。进行了 CD68(巨噬细胞标志物)的免疫组织化学染色,并进行了盲法评估。我们发现,TAMs 在高组织病理学分级的乳腺癌患者中更为常见。TAMs 密度高的乳腺癌患者无病生存率和 5 年总生存率明显低于 TAMs 密度低的患者。此外,TAMs 的高浸润预示着无淋巴结转移的乳腺癌患者的生存率更差。总之,肿瘤基质中 TAMs 的数量是乳腺癌患者生存时间的独立预测因子。TAMs 的高浸润是浸润性乳腺癌患者预后不良的显著危险因素,因此是一种潜在的有用的乳腺癌预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6227/3786995/a824f643e64e/pone.0076147.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6227/3786995/47dfdbb5c82c/pone.0076147.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6227/3786995/0f1a1b3c189f/pone.0076147.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6227/3786995/a824f643e64e/pone.0076147.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6227/3786995/47dfdbb5c82c/pone.0076147.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6227/3786995/0f1a1b3c189f/pone.0076147.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6227/3786995/a824f643e64e/pone.0076147.g003.jpg

相似文献

1
High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer.肿瘤相关巨噬细胞高浸润预测淋巴结阴性乳腺癌不良临床结局。
PLoS One. 2013 Sep 30;8(9):e76147. doi: 10.1371/journal.pone.0076147. eCollection 2013.
2
The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.肿瘤内分布影响 CD68 和 CD204 阳性巨噬细胞在非小细胞肺癌中的预后影响。
Lung Cancer. 2018 Sep;123:127-135. doi: 10.1016/j.lungcan.2018.07.015. Epub 2018 Jul 19.
3
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.CD68、CD163 和基质金属蛋白酶 9(MMP-9)在乳腺肿瘤微环境中的共定位在 ER 阳性和阴性癌症中的生存预测结果不同。
Breast Cancer Res. 2018 Dec 17;20(1):154. doi: 10.1186/s13058-018-1076-x.
4
Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.浸润性乳腺癌中肿瘤相关巨噬细胞的病理评估及其组织学定位。
J Egypt Natl Canc Inst. 2020 Jan 27;32(1):6. doi: 10.1186/s43046-020-0018-8.
5
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.肿瘤相关巨噬细胞存在于肿瘤基质中作为乳腺癌患者的预后标志物。
BMC Cancer. 2012 Jul 23;12:306. doi: 10.1186/1471-2407-12-306.
6
Is overexpression of CD163 and CD47 in tumour cells of breast carcinoma implicated in the recruitment of tumour-associated macrophages (TAMs) in tumour microenvironment? immunohistochemical prognostic study.乳腺癌肿瘤细胞中 CD163 和 CD47 的过表达是否参与招募肿瘤微环境中的肿瘤相关巨噬细胞(TAMs)?免疫组织化学预后研究。
J Immunoassay Immunochem. 2024 Jul 3;45(4):342-361. doi: 10.1080/15321819.2024.2358879. Epub 2024 May 30.
7
The role of tumor-associated macrophages in breast carcinoma invasion and metastasis.肿瘤相关巨噬细胞在乳腺癌侵袭和转移中的作用。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6656-64. eCollection 2015.
8
Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.肿瘤相关巨噬细胞在卵巢癌中的预后意义:一项荟萃分析。
Gynecol Oncol. 2017 Oct;147(1):181-187. doi: 10.1016/j.ygyno.2017.07.007. Epub 2017 Jul 8.
9
Spatial interaction and functional status of CD68SHP2 macrophages in tumor microenvironment correlate with overall survival of NSCLC.肿瘤微环境中 CD68SHP2 巨噬细胞的空间相互作用和功能状态与 NSCLC 的总生存相关。
Front Immunol. 2024 May 10;15:1396719. doi: 10.3389/fimmu.2024.1396719. eCollection 2024.
10
Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.肿瘤相关巨噬细胞在乳腺癌中的预后意义:文献的荟萃分析
Oncotarget. 2017 May 2;8(18):30576-30586. doi: 10.18632/oncotarget.15736.

引用本文的文献

1
Total, not isoform-specific, Lyn expression by macrophages promotes TLR activation and restricts proliferation.巨噬细胞的Lyn表达总量(而非特定亚型)可促进Toll样受体(TLR)激活并限制增殖。
bioRxiv. 2025 Jul 10:2025.07.07.663098. doi: 10.1101/2025.07.07.663098.
2
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.重编程乳腺肿瘤免疫微环境:从冷到热的转变以增强免疫治疗
J Exp Clin Cancer Res. 2025 Apr 25;44(1):131. doi: 10.1186/s13046-025-03394-8.
3
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.

本文引用的文献

1
Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers.乳腺癌表型、淋巴结状态和可触及性可能有助于检测过度诊断的筛查发现乳腺癌。
Ann Oncol. 2013 Jul;24(7):1847-1852. doi: 10.1093/annonc/mdt179. Epub 2013 May 16.
2
Immune-suppressive properties of the tumor microenvironment.肿瘤微环境的免疫抑制特性。
Cancer Immunol Immunother. 2013 Jul;62(7):1137-48. doi: 10.1007/s00262-013-1434-6. Epub 2013 May 11.
3
Tumor-associated macrophages: functional diversity, clinical significance, and open questions.
嵌合抗原受体巨噬细胞疗法治疗HER2过表达晚期实体瘤:一项1期试验
Nat Med. 2025 Apr;31(4):1171-1182. doi: 10.1038/s41591-025-03495-z. Epub 2025 Feb 7.
4
Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function.三阴性乳腺癌细胞分泌的半乳糖凝集素-3调节T细胞功能。
Neoplasia. 2025 Feb;60:101117. doi: 10.1016/j.neo.2024.101117. Epub 2024 Dec 27.
5
Unraveling Macrophage Polarization: Functions, Mechanisms, and "Double-Edged Sword" Roles in Host Antiviral Immune Responses.解析巨噬细胞极化:在宿主抗病毒免疫反应中的功能、机制和“双刃剑”作用。
Int J Mol Sci. 2024 Nov 10;25(22):12078. doi: 10.3390/ijms252212078.
6
Siglec-7 and Siglec-9 expression in primary triple negative and oestrogen receptor positive breast cancer and signalling.Siglec-7和Siglec-9在原发性三阴性和雌激素受体阳性乳腺癌中的表达及信号传导
Clin Transl Immunology. 2024 Sep 6;13(9):e1524. doi: 10.1002/cti2.1524. eCollection 2024 Sep.
7
High M2-TAM Infiltration and STAT3/NF-κB Signaling Pathway as a Predictive Factor for Tumor Progression and Death in Cervical Cancer.高M2型肿瘤相关巨噬细胞浸润及STAT3/NF-κB信号通路作为宫颈癌肿瘤进展和死亡的预测因素
Cancers (Basel). 2024 Jul 9;16(14):2496. doi: 10.3390/cancers16142496.
8
The Tumor Immune Microenvironment in Breast Cancer Progression.乳腺癌进展中的肿瘤免疫微环境。
Acta Oncol. 2024 May 23;63:359-367. doi: 10.2340/1651-226X.2024.33008.
9
CATD: a reproducible pipeline for selecting cell-type deconvolution methods across tissues.CATD:一种用于跨组织选择细胞类型反卷积方法的可重复流程。
Bioinform Adv. 2024 Mar 23;4(1):vbae048. doi: 10.1093/bioadv/vbae048. eCollection 2024.
10
IL-8 Instructs Macrophage Identity in Lateral Ventricle Contacting Glioblastoma.白细胞介素-8在侧脑室接触性胶质母细胞瘤中决定巨噬细胞特性。
bioRxiv. 2024 Mar 30:2024.03.29.587030. doi: 10.1101/2024.03.29.587030.
肿瘤相关巨噬细胞:功能多样性、临床意义及未解决问题
Semin Immunopathol. 2013 Sep;35(5):585-600. doi: 10.1007/s00281-013-0367-7. Epub 2013 May 9.
4
The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.CD163+ 和 CD68+ 巨噬细胞在肝癌患者中的临床意义。
PLoS One. 2013;8(3):e59771. doi: 10.1371/journal.pone.0059771. Epub 2013 Mar 29.
5
New prognostic factors in breast cancer.乳腺癌的新预后因素。
Adv Clin Exp Med. 2013 Jan-Feb;22(1):5-15.
6
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer.肿瘤相关巨噬细胞作为乳腺癌潜在的诊断和预后生物标志物。
Cancer Lett. 2013 May 10;332(1):3-10. doi: 10.1016/j.canlet.2013.01.024. Epub 2013 Jan 21.
7
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
8
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.肿瘤相关巨噬细胞在实体瘤中的预后意义:文献的荟萃分析。
PLoS One. 2012;7(12):e50946. doi: 10.1371/journal.pone.0050946. Epub 2012 Dec 28.
9
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.免疫抑制性肿瘤网络:髓源抑制性细胞、调节性 T 细胞和自然杀伤 T 细胞。
Immunology. 2013 Feb;138(2):105-15. doi: 10.1111/imm.12036.
10
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.局部复发或转移性乳腺癌:ESMO临床实践指南之诊断、治疗与随访
Ann Oncol. 2012 Oct;23 Suppl 7:vii11-9. doi: 10.1093/annonc/mds232.